Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Socrates Tzartos

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society|April 5, 2002
The production of anti-hexapeptide antibodies which recognize the S7, L6 and L13 ribosomal proteins of Escherichia coliAristomenis Metaxas, Socrates Tzartos, Maria Liakopoulou-Kyriakide
Noro Psikiyatri Arsivi|December 12, 2025
MOG and GFAP Antibodies are not Present in Headache with Neurological Deficits and Cerebrospinal Fluid Lymphocytosis (HaNDL)Maria Pechlivanidou, Elif Şanlı, Murat Kürtüncü, et al.
International Journal of Biological Macromolecules|July 12, 2014
Purification and functional characterization of a truncated human α4β2 nicotinic acetylcholine receptorNikolaos Kouvatsos, Athanasios Niarchos, Paraskevi Zisimopoulou, et al.
International Immunopharmacology|April 19, 2015
Inflammation decreases the level of alpha7 nicotinic acetylcholine receptors in the brain mitochondria and makes them more susceptible to apoptosis inductionOlena Lykhmus, Galyna Gergalova, Marios Zouridakis, et al.
Clinical Neuropathology|February 18, 2017
Recurrent tumefactive demyelinating lesions: a pathological studyRecai Türkoğlu, Hans Lassmann, Fügen Vardar Aker, et al.
International Journal of Molecular Sciences|August 23, 2020
Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting ImplicationsKonstantinos Farsalinos, Elias Eliopoulos, Demetres D Leonidas, et al.
Nature Reviews. Neurology|April 23, 2016
Myasthenia gravis - autoantibody characteristics and their implications for therapyNils Erik Gilhus, Geir Olve Skeie, Fredrik Romi, et al.
Cytometry. Part B, Clinical Cytometry|October 1, 2008
A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell linesDennis Keefe, Donna Hess, Jennifer Bosco, et al.
Immunobiology|August 9, 2016
The role of carbohydrate component of recombinant α7 nicotinic acetylcholine receptor extracellular domain in its immunogenicity and functional effects of resulting antibodiesOlena Lykhmus, Lyudmyla Koval, Dar'ya Pastuhova, et al.
Frontiers in Pharmacology|September 12, 2022
Corrigendum: Crystal structure of the monomeric extracellular domain of α9 nicotinic receptor subunit in complex with α-conotoxin RgIA: Molecular dynamics insights into RgIA binding to α9α10 nicotinic receptorsMarios Zouridakis, Athanasios Papakyriakou, Igor A Ivanov, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of Peptide Science : an Official Publication of the European Peptide Society|April 5, 2002
The production of anti-hexapeptide antibodies which recognize the S7, L6 and L13 ribosomal proteins of Escherichia coliAristomenis Metaxas, Socrates Tzartos, Maria Liakopoulou-Kyriakide
Noro Psikiyatri Arsivi|December 12, 2025
MOG and GFAP Antibodies are not Present in Headache with Neurological Deficits and Cerebrospinal Fluid Lymphocytosis (HaNDL)Maria Pechlivanidou, Elif Şanlı, Murat Kürtüncü, et al.
International Journal of Biological Macromolecules|July 12, 2014
Purification and functional characterization of a truncated human α4β2 nicotinic acetylcholine receptorNikolaos Kouvatsos, Athanasios Niarchos, Paraskevi Zisimopoulou, et al.
International Immunopharmacology|April 19, 2015
Inflammation decreases the level of alpha7 nicotinic acetylcholine receptors in the brain mitochondria and makes them more susceptible to apoptosis inductionOlena Lykhmus, Galyna Gergalova, Marios Zouridakis, et al.
Clinical Neuropathology|February 18, 2017
Recurrent tumefactive demyelinating lesions: a pathological studyRecai Türkoğlu, Hans Lassmann, Fügen Vardar Aker, et al.
International Journal of Molecular Sciences|August 23, 2020
Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting ImplicationsKonstantinos Farsalinos, Elias Eliopoulos, Demetres D Leonidas, et al.
Nature Reviews. Neurology|April 23, 2016
Myasthenia gravis - autoantibody characteristics and their implications for therapyNils Erik Gilhus, Geir Olve Skeie, Fredrik Romi, et al.
Cytometry. Part B, Clinical Cytometry|October 1, 2008
A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell linesDennis Keefe, Donna Hess, Jennifer Bosco, et al.
Immunobiology|August 9, 2016
The role of carbohydrate component of recombinant α7 nicotinic acetylcholine receptor extracellular domain in its immunogenicity and functional effects of resulting antibodiesOlena Lykhmus, Lyudmyla Koval, Dar'ya Pastuhova, et al.
Frontiers in Pharmacology|September 12, 2022
Corrigendum: Crystal structure of the monomeric extracellular domain of α9 nicotinic receptor subunit in complex with α-conotoxin RgIA: Molecular dynamics insights into RgIA binding to α9α10 nicotinic receptorsMarios Zouridakis, Athanasios Papakyriakou, Igor A Ivanov, et al.
Pageof 6